---
title: "Publications of the group"
date: last-modified
execute:   
  freeze: auto  # re-render only when source changes
output: 
  rmarkdown::html_document:
    highlight: pygments
    number_sections: yes
    self_contained: yes
    toc: yes
    toc_depth: 3
    toc_float: yes
---

Here we list the publications that the group has written or contributed to:

- *B. C. Kahan, J. Hindley, M. Edwards, S. Cro, T. P. Morris*. **The estimands framework: a primer on the ICH E9(R1) addendum**. ***BMJ***. 384:e076316 (2024) <https://doi.org/10.1136/bmj-2023-076316>
- *O. N. Keene, H. Lynggaard , S. Englert, V. Lanius, D. Wright*. **Why Estimands are Needed to Define Treatment Effects in Clinical Trials**. ***BMC Medicine***. 21:276 (2023) <https://doi.org/10.1186/s12916-023-02969-6>
- *B. C. Kahan, I. R. White, M. Edwards, M. O. Harhay*. **Using modified intention-to-treat as a principal stratum estimator for failure to initiate treatment**. ***Clinical Trials*** 20(3):269-275 (2023)  <https://doi.org/10.1177/17407745231160074>
- *A. Morga, NR. Latimer, M. Scott, N. Hawkins, M. Schlichting, J. Wang*. **Is Intention to Treat Still the Gold Standard or Should Health Technology Assessment Agencies Embrace a Broader Estimands Framework?: Insights and Perspectives From NICE and IQWiG on the ICH E9(R1) Addendum**. ***Value Health***. 2022 Sep 20:S1098-3015(22)02148-9. <https://doi.org/10.1016/j.jval.2022.08.008> 
- *H. Lynggaard, J. Bell, C. Lösch, A. Besseghir, K. Rantell, V. Schoder, V. Lanius*. **Principles and Recommendations for Incorporating Estimands into Clinical Study Protocol Templates**. ***Trials*** (2022) <https://doi.org/10.1186/s13063-022-06515-2> 
- *C. Fletcher, N. Hefting, M. Wright, J. Bell, J. Anzures-Cabrera, D Wright, H. Lynggaard, A. Schueler*. **Marking 2-years of new thinking in clinical trials - the estimand journey**. ***Ther Innov Regul Sci*** 56, 637–650 (2022). <https://doi.org/10.1007/s43441-022-00402-3> 
- *O. N. Keene, D. Wright, A. Phillips, M. Wright*. **Why ITT analysis is not always the answer for estimating treatment effects in clinical trials**. ***Contemporary Clinical Trials***. (2021) <https://doi.org/10.1016/j.cct.2021.106494> 



